Skip to main content
Clinical Trials/NCT02714179
NCT02714179
Completed
Phase 4

A Double Blind Randomised Controlled Trial of Preemptive and Preventive Use of Paracetamol for Pain Relief After Cesarean Section

Baskent University0 sites54 target enrollmentMay 2015

Overview

Phase
Phase 4
Intervention
Paracetamol was given intravenously in both group at different times
Conditions
Cesarean Section; Dehiscence
Sponsor
Baskent University
Enrollment
54
Primary Endpoint
Visual analog score (VAS) for pain
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The investigators designed a prospective randomized study to investigate the efficacy of intravenous (IV) preemptive versus preventive paracetamol on postoperative pain scores, patient satisfaction, total morphine consumption and the incidence of morphine-related side effects in patients undergoing cesarean section.

Registry
clinicaltrials.gov
Start Date
May 2015
End Date
January 2016
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ozlem Ozmete

Medical Doctor

Baskent University

Eligibility Criteria

Inclusion Criteria

  • 38 weeks pregnancy, elective cesarean section.

Exclusion Criteria

  • morbid obesity, cardiac failure, depression.

Arms & Interventions

Group Preemptive (Group PE),

Group I: i.V. paracetamol 1 g (100 ml) was given 30 min before induction of anesthesia.

Intervention: Paracetamol was given intravenously in both group at different times

Group Preventive (Group PV),

Group II: i.V. paracetamol 1 g (100 ml) was given before the end of surgery.

Intervention: Paracetamol was given intravenously in both group at different times

Outcomes

Primary Outcomes

Visual analog score (VAS) for pain

Time Frame: 24 hours

Similar Trials